Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Inoue

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
BMC Cancer|October 13, 2019
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)Hiroaki Tanioka, Takeshi Nagasaka, Futoshi Uno, et al.
Japanese Journal of Clinical Oncology|July 31, 2023
Current prognostic factors of advanced gastric cancer patients treated with chemotherapy: real world data from a Japanese 12 institutionsShumpei Yamamoto, Hiromitsu Kanzaki, Chihiro Sakaguchi, et al.
Plos One|March 20, 2015
Surveillance and clinical characterization of influenza in a university cohort in SingaporeAidan Lyanzhiang Tan, Ramandeep Kaur Virk, Paul Anantharajah Tambyah, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|May 11, 2016
Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiationArisa Kumagai, Fukuo Kondo, Keiji Sano, et al.
Journal of Gastroenterology and Hepatology|February 7, 2019
Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologicsToshihiro Inokuchi, Sakuma Takahashi, Sakiko Hiraoka, et al.
British Journal of Cancer|October 6, 2017
The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational studyHiroyuki Sakae, Hiromitsu Kanzaki, Junichiro Nasu, et al.
Medicine|October 1, 2021
Clinical characteristics and course of sporadic non-ampullary duodenal adenomas: A multicenter retrospective studyHiromitsu Kanzaki, Kazuhiro Matsueda, Masahiro Nakagawa, et al.
Cancer Research|July 5, 2006
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancerQuek Choon Lau, Erna Raja, Manuel Salto-Tellez, et al.
World Journal of Gastroenterology|June 25, 2016
Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux diseaseRyuta Takenaka, Hiroyuki Okada, Seiji Kawano, et al.
Journal of Medicinal Chemistry|February 26, 2024
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction InhibitorsKazuki Otake, Yoshinori Hara, Minoru Ubukata, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
BMC Cancer|October 13, 2019
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)Hiroaki Tanioka, Takeshi Nagasaka, Futoshi Uno, et al.
Japanese Journal of Clinical Oncology|July 31, 2023
Current prognostic factors of advanced gastric cancer patients treated with chemotherapy: real world data from a Japanese 12 institutionsShumpei Yamamoto, Hiromitsu Kanzaki, Chihiro Sakaguchi, et al.
Plos One|March 20, 2015
Surveillance and clinical characterization of influenza in a university cohort in SingaporeAidan Lyanzhiang Tan, Ramandeep Kaur Virk, Paul Anantharajah Tambyah, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|May 11, 2016
Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiationArisa Kumagai, Fukuo Kondo, Keiji Sano, et al.
Journal of Gastroenterology and Hepatology|February 7, 2019
Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologicsToshihiro Inokuchi, Sakuma Takahashi, Sakiko Hiraoka, et al.
British Journal of Cancer|October 6, 2017
The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational studyHiroyuki Sakae, Hiromitsu Kanzaki, Junichiro Nasu, et al.
Medicine|October 1, 2021
Clinical characteristics and course of sporadic non-ampullary duodenal adenomas: A multicenter retrospective studyHiromitsu Kanzaki, Kazuhiro Matsueda, Masahiro Nakagawa, et al.
Cancer Research|July 5, 2006
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancerQuek Choon Lau, Erna Raja, Manuel Salto-Tellez, et al.
World Journal of Gastroenterology|June 25, 2016
Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux diseaseRyuta Takenaka, Hiroyuki Okada, Seiji Kawano, et al.
Journal of Medicinal Chemistry|February 26, 2024
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction InhibitorsKazuki Otake, Yoshinori Hara, Minoru Ubukata, et al.
Pageof 9